Giovanna Rege‐Cambrin

Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome–positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol

Marco Vignetti, Paola Fazi, Giuseppe Cimino et al. · Blood · 2007 · 373 citations · Full text

Medicine, Oncology, Pharmacotherapy +15

Dasatinib induces rapid hematologic and cytogenetic responses in adult patients with Philadelphia chromosome–positive acute lymphoblastic leukemia with resistance or intolerance to imatinib: interim results of a phase 2 study

Oliver G. Ottmann, Hervé Dombret, Giovanni Martinelli et al. · Blood · 2007 · 369 citations · Full text

Life Sciences, Hematology, Oncology +16

MEC1 and MEC2: two new cell lines derived from B-chronic lymphocytic leukaemia in prolymphocytoid transformation

Alessandra Stacchini, M. Aragno, Antonella Vallario et al. · Leukemia Research · 1999 · 278 citations

Life Sciences, Cell Biology, Hematology +9

Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients

Daniela Cilloni, Enrico Gottardi, Daniela De Micheli et al. · Leukemia · 2002 · 243 citations

Medicine, Hematology, Oncology +17

Efficacy and safety of dasatinib in imatinib-resistant or -intolerant patients with chronic myeloid leukemia in blast phase

Jörge E. Cortes, D-W Kim, Emmanuel Raffoux et al. · Leukemia · 2008 · 201 citations

Medicine, Pharmacology, Pharmacotherapy +8